Chronic obstructive pulmonary disease (COPD) remains a substantial contributor to morbidity and mortality in the United States with an estimated 3.8% age-adjusted prevalence and 141,733 COPD deaths ...

The role of combination therapy is explored for the treatment of COPD. Jeffrey D. Dunn, PharmD, MBA: Let’s discuss guideline-based disease management. I’m going to address this first question to Rey.

The European Medicines Agency (EMA) has released a new guideline on clinical trials conducted to assess chronic obstructive pulmonary disease (COPD) products, updating an existing guideline regulators ...

The American Lung Association today announced the launch of the COPD-OMA trial, a national clinical research effort conducted through its Airways Clinical Research Centers (ACRC). The study will ...

David Mannino is co-founder and chief medical officer of the COPD Foundation. He's an internal medicine doctor with a specialty in pulmonary, critical care, and sleep medicine at University of ...

lung xray_TS_159291221 Clinician awareness of COPD treatment guidelines has increased since 2007. Clinicians report multiple barriers preventing the diagnosis of chronic obstructive pulmonary disease ...

Please provide your email address to receive an email when new articles are posted on . Remodeling may include more smooth muscle mass and epithelial cell shedding. Macrolides, vaccination and ...

CBD has been shown to have strong anti-inflammatory effects. However, more research is needed to determine if CBD oil has the potential to become a part of prescribed COPD management. Cannabidiol (CBD ...

Chronic Obstructive Pulmonary Disease (COPD) is a progressive disease in which shortness of breath is a common symptom. The feeling of breathlessness can cause panic, and even lead to a drop in your ...